Author Interviews, Heart Disease / 12.09.2013
AFib: Progression after Failed Ablation Drug Therapy vs Re-Ablation
MedicalResearch.com Interview with:
Dr. Evgeny Pokushalov, MD, PhD
State Research Institute of Circulation Pathology, Rechkunovskaya 15, 630055 Novosibirsk 55, Russia
MedicalResearch.com: What are the main findings of the study?
Dr. Pokushalov: The main finding of this study is that after the failure of the first catheter ablation procedure for PAF, a redo ablation was more effective at eradicating recurrent AF than treatment with AAD.
In this randomized controlled clinical trial, we observed that:
1. The AF progression rate was considerably higher in patients randomized to AAD (79%) use compared with patients treated with a second ablation procedure (25%).
2. The AF burden significantly increased on AAD during followup compared with patients of reablation group (18.8±11.4% versus 5.6±9.5%, respectively).
3. There was a much greater rate of progression to persistent AF if AAD was used rather than redo ablation (23% versus 4%, respectively).
These findings support the need for consideration of a timely intervention in patients with PAF who have responded inadequately to an initial PVI.












